We are live on ! Find out more
MB

MPM BioImpact Portfolio holdings

AUM $1.29B
1-Year Est. Return 141.72%
This Fund
S&P 500
This Quarter Est. Return
+29.46%
1 Year Est. Return
+141.72%
3 Year Est. Return
+440.65%
5 Year Est. Return
+290.21%
10 Year Est. Return
–
AUM
$611M
AUM Growth
+$33.7M
Cap. Flow
-$56.3M
Cap. Flow %
-9.22%
Top 10 Hldgs %
48.78%
Holding
51
New
7
Increased
4
Reduced
2
Closed
11

Top Buys

1
SNDX icon
Syndax Pharmaceuticals
SNDX
+$18M
2
SLNO
Soleno Therapeutics
SLNO
+$7.41M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$6.74M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$6.34M
5
LQDA icon
Liquidia Corp
LQDA
+$4.34M

Top Sells

1
GH icon
Guardant Health
GH
+$23M
2
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$14.8M
3
MBX
MBX Biosciences
MBX
+$14.8M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$12.3M
5
OLMA icon
Olema Pharmaceuticals
OLMA
+$10.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBX
51
MBX Biosciences
MBX
$2.89B
– –
-1,294,416
Closed -$14.8M
1 2
3

Similar funds

MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
ACM
Alta Capital Management Salt Lake City, Utah $1.29B AUM 17.57% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
COCM
Charter Oak Capital Management Portsmouth, New Hampshire $1.29B AUM 13.93% 1-Year Est. Return
MA
MONECO Advisors Fairfield, Connecticut $1.29B AUM 18.01% 1-Year Est. Return